PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma
Buckley, Hannah L., Collinson, Fiona J., Ainsworth, Gemma, Poad, Heather, Flanagan, Louise, Katona, Eszter, Howard, Helen C., Murden, Geraldine, Banks, Rosamonde E., Brown, Joanne, Velikova, Galina, WVolume:
19
Language:
english
Journal:
BMC Cancer
DOI:
10.1186/s12885-019-6273-1
Date:
December, 2019
File:
PDF, 981 KB
english, 2019